Trexall

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:approves 1953
gptkbp:brand gptkb:Rheumatrex
gptkb:Otrexup
Xatmep
gptkbp:category gptkb:X
gptkbp:class gptkb:immunotherapy
gptkb:oppression
gptkbp:contraindication alcohol consumption
pregnancy
gptkbp:dosage_form 10 mg
oral tablet
50 mg
15 mg
25 mg
2.5 mg
gptkbp:formulation gptkb:tablet
https://www.w3.org/2000/01/rdf-schema#label Trexall
gptkbp:ingredients gptkb:methotrexate
gptkbp:interacts_with NSAIDs
antibiotics
live vaccines
sulfonamides
gptkbp:is_monitored_by liver function tests
complete blood count
renal function tests
gptkbp:lifespan 8 to 15 hours
gptkbp:manufacturer various pharmaceutical companies
gptkbp:mechanism_of_action inhibits dihydrofolate reductase
gptkbp:metabolism hepatic
gptkbp:patient_education avoid alcohol
stay hydrated
report signs of infection
regular blood tests required
gptkbp:requires prescription only
gptkbp:rounds renal
gptkbp:route_of_administration oral
gptkbp:side_effect fatigue
nausea
liver toxicity
mouth sores
gptkbp:storage room temperature
gptkbp:structure C20 H22 N8 O5
gptkbp:used_for treatment of psoriasis
treatment of rheumatoid arthritis
gptkbp:bfsParent gptkb:methotrexate
gptkbp:bfsLayer 5